Breaking UN Chief Urges Cyprus Resolution for Regional Stability Atlanta Falcons Face Quarterback Scarcity Amidst Training Camp Injuries and Roster Moves Indiana Fever Players Unavailable to Media Following Game Amidst Controversy French Electronic Composer Kavinsky Dies at 50 Botched Entrance Exams Spark Nationwide Youth Protests in India, Leading to Education Minister’s Resignation

Wednesday July 29, 2026

Reporter

NanoViricides

4Articles Published

4Communities Covered

Published Articles

Press Release

NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial

Jul 28

Press Release

NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering

Jul 24

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 23

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 22